Navigation Links
Celator(R) Pharmaceuticals Presents Phase 1 Results With CPX-351 in Patients With Advanced Leukemia at the American Society of Hematology Meeting
Date:12/9/2008

delivered by CPX-351 to human leukemia xenografts is associated with liposome-mediated bone marrow drug accumulation, intracellular delivery of encapsulated agents to leukemia cells, and increase efficacy.

Poster presented Saturday, December 6, 2008.

ASH Abstract # 2984

Feldman EJ, Lancet J, Kolitz EJ, et al. Phase 1 study of a liposomal carrier (CPX-351) containing a synergistic, fixed molar ratio of cytarabine (Ara-C) and daunorubicin (DNR) in advanced leukemias.

Poster presented Monday, December 8, 2008.


'/>"/>
SOURCE Celator Pharmaceuticals
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. Frederick R. Appelbaum, M.D. and Ross C. Donehower, M.D. Join Scientific Advisory Board of Celator(R) Pharmaceuticals
2. Arena Pharmaceuticals to Host Research & Development Day on December 15, 2008
3. Arena Pharmaceuticals Announces Lorcaserin Phase 2b Clinical Trial Results Published in Obesity
4. Savient Pharmaceuticals to Present at the 27th Annual J.P. Morgan Healthcare Conference on January 14th
5. ISTA Pharmaceuticals to Participate at the RBC Capital Markets Healthcare Conference
6. Middlebrook Pharmaceuticals Opens Administrative and Sales Office in Westlake, Texas
7. Memory Pharmaceuticals Receives NASDAQ Decisions
8. MAP Pharmaceuticals to Present at the 2008 RBC Capital Markets Healthcare Conference
9. The Westaim Corporation requisitions meeting of shareholders of NUCRYST Pharmaceuticals to return capital to NUCRYST shareholders
10. Quark Pharmaceuticals to Present at the 20th Annual Piper Jaffray Health Care Conference
11. Transcept Pharmaceuticals to Participate on Drug Delivery Investor Panel
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2015)... Rolling Meadows, Ill. (PRWEB) , ... September 01, ... ... medical procedures done by members of the American Society for Dermatologic Surgery, according ... case. , The 2015 ASDS Consumer Survey on Cosmetic Dermatologic Procedures – which ...
(Date:9/1/2015)... , ... September 01, 2015 , ... ... is now offering the MonaLisa Touch® , an innovative vaginal health laser ... Touch® is a new hormone-free treatment for atrophic vaginitis, a condition that causes ...
(Date:9/1/2015)... ... September 01, 2015 , ... With former IBMers among its founding members, ... its inception more than 35 years ago. A pilot program begun by the company ... and, not just those intent on pursuing careers in these fields. The program is ...
(Date:9/1/2015)... ... 2015 , ... WorkCare, Inc., a national occupational health services ... as an Associate Medical Director. , WorkCare specializes in workforce health protection ... abroad. , Dr. Nelson has a diverse background. He trained in sports ...
(Date:9/1/2015)... ... September 01, 2015 , ... ... Laboratory Instruments in accordance with GMP requirements“ , featuring Ed Szczesny (Quality Assurance, ... 2015 at 11:00 EDT (15:00 GMT). , Calibration, qualification, and the appropriate ...
Breaking Medicine News(10 mins):Health News:Survey: Consumers Prefer ASDS Members 2Health News:Survey: Consumers Prefer ASDS Members 3Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 2Health News:Houston's Plaza OB/GYN Now Offering the MonaLisa Touch® 3Health News:Inmar Announces Program to Fuel Student Passion for STEM – with an Unconventional Twist 2Health News:Dr. Brent Nelson Joins WorkCare, Inc., as Associate Medical Director 2Health News:Dr. Brent Nelson Joins WorkCare, Inc., as Associate Medical Director 3Health News:Live Webinar from Pharmaceutical Technology and METTLER TOLEDO on Calibration and Qualification of Laboratory Instruments 2
... evaluationGRAND RAPIDS, Mich., Feb. 13 Sentinel Group announced ... Sense(TM) Device. The study was conducted at Galenia ... MD, James Foote MD and Mexican doctor Jorge Trevino ... the devices implanted for 6 weeks to evaluate weight ...
... China,s leading,integrated medical device and healthcare services provider, ... HKEx: 8180) is pleased to,announce today the third ... ended December 31, 2008. The Group recorded HK$377,707,000 ... on a year-on-year basis. , ...
... (TSX:HAE) announces that it has implemented cost-cutting measures in ... Company will continue to seek financing and will initiate ... merger of the Company. , Haemacure has been seeking ... have expressed interest in an equity financing; however, this ...
... Stemedica Cell Technologies, Inc., a leader in adult stem cell development, ... Director of Manufacturing and Clinical Business Development of Stemedica International, CH. ... operations to Stemedica,s International,s center based in Lausanne, Switzerland. , ... ...
... in Superior Court for the Commonwealth of MassachusettsVANCOUVER, ... QLTI ; TSX: QLT) announced that on ... business as Massachusetts General Hospital ("MGH"), filed a ... of Massachusetts against QLT Phototherapeutics (Canada), Inc. QLT ...
... Results are better with brief immobilization than with bandage or ... People with severe ankle sprains recover faster with a short ... brace than with the use of either a tubular compression ... , Along with receiving one of the four ...
Cached Medicine News:Health News:Weight Loss Without Hunger! 2Health News:Golden Meditech Releases FY2008/09 Q3 Results 2Health News:Golden Meditech Releases FY2008/09 Q3 Results 3Health News:Haemacure Restructures - Seeks Financing or Sale of the Company 2Health News:Haemacure Restructures - Seeks Financing or Sale of the Company 3Health News:Stemedica Announces the Appointment of Riccardo Nisato, MBA, PhD as Director of Manufacturing and Clinical Business Development for Stemedica International 2Health News:Stemedica Announces the Appointment of Riccardo Nisato, MBA, PhD as Director of Manufacturing and Clinical Business Development for Stemedica International 3Health News:QLT announces that it is named as a defendant in an action 2Health News:QLT announces that it is named as a defendant in an action 3Health News:Casting Seems Best for Severe Ankle Sprains 2
(Date:9/1/2015)... -- Sleep Specialists, LLC a medical device company ... Solutions, a leader in digital health and chronic ... and cost reduction program for patients with Obstructive ... chronic medical condition characterized by periods of interrupted ... risk for cardiovascular disease, hypertension, stroke, congestive heart ...
(Date:9/1/2015)... 1, 2015 Taiwan,s ... conference in Taipei on  August ... Vaucarrin™ platform, a targeted drug delivery technology that uses ... This event was part of a joint press conference held ... Inc. (GNT), showcasing GNT,s latest edible gold-based food and ...
(Date:9/1/2015)... 1, 2015 The global ... basis of sectors, products & services and application. And ... with the increasing demand of advanced drugs for ... propel the growth for bioinformatics market. The implementation ... is known as bioinformatics. Decreasing cost of DNA ...
Breaking Medicine Technology:Sleep Specialists, LLC and HGE Health Care Solutions Announce Comprehensive Sleep Program 2GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 2GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 3GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 4GNTbm Updates Developments in the Vaucarrin(TM) annogold Drug Delivery Platform 5Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 2Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 3Global Bioinformatics Market Valued at Over $1.3 Billion in 2013 and is Expected to Grow at CAGR of 20.3% From 2014 to 2020: Hexa Research 4
... 2012 MAP Pharmaceuticals, Inc. (Nasdaq: MAPP ) today ... The net loss for the first quarter ended ... of $16.0 million during the same period in 2011. The net ... one-time expense of $2.8 million for the purchase of a data ...
... 3, 2012  Gen-Probe Incorporated (NASDAQ: GPRO ) announced ... upcoming investor conferences previously announced on April 26, 2012, and ... conferences: , Deutsche Bank 37th Annual Health Care ... Time;  , Baird,s 2012 Growth Stock Conference in Chicago ...
Cached Medicine Technology:MAP Pharmaceuticals Reports First Quarter of 2012 Financial Results 2MAP Pharmaceuticals Reports First Quarter of 2012 Financial Results 3MAP Pharmaceuticals Reports First Quarter of 2012 Financial Results 4MAP Pharmaceuticals Reports First Quarter of 2012 Financial Results 5Gen-Probe Withdraws from Previously Announced Investor Presentations 2
The MC-3 allows for simultaneous use of two lamps, with an additional built-in spare....
... a high light intensity. Light ... different brightness steps (Halogen 150) ... output can be adapted to ... small diameter scope, etc.). Different ...
Cold light source single outlet....
Cold light source single outlet....
Medicine Products: